News | January 12, 2010

Endothelial Function Test Named a Top Medical Breakthrough

January 12, 2010 – In its January issue, Prevention magazine named the Endo-PAT2000 endothelial function testing device one of the top medical breakthroughs of 2009.

The American Heart Association said 50 percent of coronary deaths occur in people with no previous symptoms, but a study by the Mayo Clinic suggests measuring endothelial function can aid diagnosis. The seven-year Mayo Clinic and Tufts-New England Medical Center study published in April 2009 found the measuring vessel health can help diagnosis a variety of medical conditions, including coronary artery disease, heart attack, stroke, sleep apnea, pre-eclamptic toxemia, and erectile dysfunction.

The study suggests a patient with low risk (based on Framingham Risk Score) but high endothelial dysfunction is 300 percent more likely to have a heart attack than a patient with low risk and no endothelial dysfunction. In the study, 49 percent of patients whose Endo-PAT test indicated poor endothelial function had a cardiac event during the seven-year study.

Amir Lerman, M.D., a cardiologist at the Mayo Clinic, explained that a “poor score is a stronger warning than the usual risk factors, because it indicates that cardiovascular disease has already begun – but at an early stage when you can more easily control your risks.”

The medical technology company Medvica International is among the first companies to market the Endo-PAT2000 in North America. The device uses sensors that measure blood flow through a patient’s fingers. Endothelial cells line the inner walls of blood vessels, lymph vessels, and the heart, and damage to them may be an early sign of heart disease. The device is small enough to sit on a table for office-based use. The test takes 15-minutes.

Endo-PAT testing is reimbursable by Medicare and covered by most major U.S. insurance companies.

For more information: www.medvica.com

Related Content

AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance or coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Alere point of care POC testing for INR
News | Point of Care Testing| July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is on
Overlay Init